{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:19:52Z","timestamp":1789154392025,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"DOI":"10.7759\/cureus.79261","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:35:27Z","timestamp":1739950527000},"source":"Crossref","is-referenced-by-count":1,"title":["Black Pigmentation on the Tongue Induced by Long-Term Use of Tetracycline Antibiotics in a Colorectal Cancer Patient With Epidermal Growth Factor Receptor (EGFR) Inhibitor-Associated Skin Lesions: A Case Report and Literature Review"],"prefix":"10.7759","author":[{"given":"Takahito","family":"Inagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takenori","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Ichikura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiko","family":"Wakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuichi","family":"Nawata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.10.010","article-title":"Dermatologic side effects associated with the epidermal growth factor receptor inhibitors","volume":"55","author":"Agero AL","year":"2006","unstructured":"Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors. J Am Acad Dermatol. 2006, 55:657-70. 10.1016\/j.jaad.2005.10.010","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.10533","article-title":"Error in text wording and incorrect reference","volume":"329","year":"2023","unstructured":"Error in text wording and incorrect reference. JAMA. 2023, 329.2196. 10.1001\/jama.2023.10533","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13740","article-title":"Prevention and management of acneiform rash associated with EGFR inhibitor therapy: a systematic review and meta-analysis","volume":"18","author":"Gorji M","year":"2022","unstructured":"Gorji M, Joseph J, Pavlakis N, Smith SD. Prevention and management of acneiform rash associated with EGFR inhibitor therapy: a systematic review and meta-analysis. Asia Pac J Clin Oncol. 2022, 18:526-39. 10.1111\/ajco.13740","journal-title":"Asia Pac J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-021-06652-5","article-title":"A multicenter study of skin toxicity management in patients with left-sided, RAS\/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?","volume":"30","author":"Antonetti P","year":"2022","unstructured":"Antonetti P, Fargnoli MC, Porzio G, et al.. A multicenter study of skin toxicity management in patients with left-sided, RAS\/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?. Support Care Cancer. 2022, 30:2455-65. 10.1007\/s00520-021-06652-5","journal-title":"Support Care Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-017-0268-y","article-title":"Black hairy tongue: predisposing factors, diagnosis, and treatment","volume":"18","author":"Schlager E","year":"2017","unstructured":"Schlager E, St Claire C, Ashack K, Khachemoune A. Black hairy tongue: predisposing factors, diagnosis, and treatment. Am J Clin Dermatol. 2017, 18:563-9. 10.1007\/s40257-017-0268-y","journal-title":"Am J Clin Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref7","unstructured":"The use of the WHO-UMC system for standardised case causality assessment. (2013). Accessed. January 27, 2025: https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199818060-00004","article-title":"Minocycline-induced pigmentation. Incidence, prevention and management","volume":"18","author":"Eisen D","year":"1998","unstructured":"Eisen D, Hakim MD. Minocycline-induced pigmentation. Incidence, prevention and management. Drug Saf. 1998, 18:431-40. 10.2165\/00002018-199818060-00004","journal-title":"Drug Saf"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1016\/j.clindermatol.2016.02.018","article-title":"Diseases of the tongue","volume":"34","author":"Mangold AR","year":"2016","unstructured":"Mangold AR, Torgerson RR, Rogers RS 3rd. Diseases of the tongue. Clin Dermatol. 2016, 34:458-69.","journal-title":"Clin Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-253811","article-title":"Minocycline-induced black hairy tongue and skin hyperpigmentation","volume":"16","author":"Takata K","year":"2023","unstructured":"Takata K, Hirai F. Minocycline-induced black hairy tongue and skin hyperpigmentation. BMJ Case Rep. 2023, 16:e253811. 10.1136\/bcr-2022-253811","journal-title":"BMJ Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/jgf2.300","article-title":"Tetracycline-induced black hairy tongue","volume":"21","author":"Sakaguchi K","year":"2020","unstructured":"Sakaguchi K, Watari T. Tetracycline-induced black hairy tongue. J Gen Fam Med. 2020, 21:80-1. 10.1002\/jgf2.300","journal-title":"J Gen Fam Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-255112","article-title":"Black hairy tongue due to antibiotics","volume":"16","author":"Okumura H","year":"2023","unstructured":"Okumura H, Kawashima A. Black hairy tongue due to antibiotics. BMJ Case Rep. 2023, 16:e255112. 10.1136\/bcr-2023-255112","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S373266","article-title":"Oral bacteria dysbiosis in patients with linezolid-induced black hairy tongue: a case series","volume":"15","author":"Shangguan Y","year":"2022","unstructured":"Shangguan Y, Ji Z, Guo W, Hu W, Li X, Xu K. Oral bacteria dysbiosis in patients with linezolid-induced black hairy tongue: a case series. Infect Drug Resist. 2022, 15:5449-54. 10.2147\/IDR.S373266","journal-title":"Infect Drug Resist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjid.2021.101633","article-title":"Black hairy tongue caused by metronidazole","volume":"25","author":"Niiyama Y","year":"2021","unstructured":"Niiyama Y, Hase R. Black hairy tongue caused by metronidazole. Braz J Infect Dis. 2021, 25:101633. 10.1016\/j.bjid.2021.101633","journal-title":"Braz J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/00368504211042982","article-title":"Linezolid-induced black hairy tongue in a patient with multidrug-resistant tuberculosis: a case report","volume":"104","author":"Lee J","year":"2021","unstructured":"Lee J, Chung HS, Roh J, Oh Y, Mok J. Linezolid-induced black hairy tongue in a patient with multidrug-resistant tuberculosis: a case report. Sci Prog. 2021, 104:368504211042982. 10.1177\/00368504211042982","journal-title":"Sci Prog"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520961279","article-title":"Antibiotic-induced black hairy tongue: two case reports and a review of the literature","volume":"48","author":"Ren J","year":"2020","unstructured":"Ren J, Zheng Y, Du H, et al.. Antibiotic-induced black hairy tongue: two case reports and a review of the literature. J Int Med Res. 2020, 48:300060520961279. 10.1177\/0300060520961279","journal-title":"J Int Med Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13066","article-title":"Reversible black tongue: a little known side effect of imipenem\/cilastatin and evidence for novel mode of action","volume":"45","author":"Zhao S","year":"2019","unstructured":"Zhao S, Fan L, Feng J, Ma P. Reversible black tongue: a little known side effect of imipenem\/cilastatin and evidence for novel mode of action. J Clin Pharm Ther. 2019, 45:370-2. 10.1111\/jcpt.13066","journal-title":"J Clin Pharm Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.251","article-title":"Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP","volume":"11","author":"Kobayashi Y","year":"2015","unstructured":"Kobayashi Y, Komatsu Y, Yuki S, et al.. Randomized controlled trial on the skin toxicity of panitumumab in Japanese patients with metastatic colorectal cancer: HGCSG1001 study; J-STEPP. Future Oncol. 2015, 11:617-27. 10.2217\/fon.14.251","journal-title":"Future Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2021.03.008","article-title":"Black hairy tongue after immune checkpoint inhibitors in NSCLC: a case report and review of the literature","volume":"22","author":"Cecchi C","year":"2021","unstructured":"Cecchi C, Mariniello A, Carnio S, Delcuratolo MD, Novello S. Black hairy tongue after immune checkpoint inhibitors in NSCLC: a case report and review of the literature. Clin Lung Cancer. 2021, 22:e804-7. 10.1016\/j.cllc.2021.03.008","journal-title":"Clin Lung Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-08012-x","article-title":"Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications","volume":"31","author":"Hannon M","year":"2023","unstructured":"Hannon M, Shaw A, Connolly M, Davies A. Taste disturbance in patients with advanced cancer: a scoping review of clinical features and complications. Support Care Cancer. 2023, 31:562. 10.1007\/s00520-023-08012-x","journal-title":"Support Care Cancer"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/334380-black-pigmentation-on-the-tongue-induced-by-long-term-use-of-tetracycline-antibiotics-in-a-colorectal-cancer-patient-with-epidermal-growth-factor-receptor-egfr-inhibitor-associated-skin-lesions-a-case-report-and-literature-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:35:32Z","timestamp":1739950532000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/334380-black-pigmentation-on-the-tongue-induced-by-long-term-use-of-tetracycline-antibiotics-in-a-colorectal-cancer-patient-with-epidermal-growth-factor-receptor-egfr-inhibitor-associated-skin-lesions-a-case-report-and-literature-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.79261","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,18]]}}}